Replies to post #324452 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

Thanks. I have no basis to disagree with that except that
it seems to me that B wouldn't be as ignored as it has been (using the share price as a yardstick) just because the results were in a human lung cell line and not in human beings IF "potential effectiveness is nearly 100 percent" means the same thing as "overall viral load was reduced by 99.85 percent".
The same questions came to mind at the time of "Innovation Pharmaceuticals’ Brilacidin Inhibits Novel Coronavirus (COVID-19) by Almost 90% at the Lowest Concentration Tested to Date in a Human Lung Cell Line"
and prior to that "Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line".)

Those are some eye-popping raw numbers and they just don't seem to fit with the market response. The pps was $15 before the first PR on 6/17, exploded to $.65 during the next week and you know where we are now after even more "good news".

But you've expressed your opinion and I appreciate it.